Boosting long-term immunity with bioengineered nanovaccines

The development of vaccine platforms capable of inducing durable immunity remains a crucial frontier. While conventional vaccines offer proven efficacy, their often limited durability poses challenges for rapidly evolving pathogens and cancer immunotherapy. Recent advances in biomaterials and nanotechnology have enabled the rational design of bioengineered nanovaccines. These systems leverage engineered polymeric, lipid-based, and hybrid materials to achieve controlled antigen release, targeted lymph node delivery, and enhanced cross-presentation. Their "bioengineered" functionality allows them to actively orchestrate sustained immune activation. This review examines the immunological foundations of long-term memory, focusing on transcriptional, epigenetic, and metabolic regulation of memory T cell differentiation. Subsequently, it explores material engineering strategies for prolonging antigen availability, refining lymph node targeting, and enhancing antigen presentation. Translational progress in infectious diseases, cancer, and chronic conditions is reviewed, with emphasis on lipid nanoparticle platforms. Finally, we discuss future directions, including intelligent biomaterials, personalized design, safety, and clinical translation pathways, providing a framework for next-generation nanovaccines against evolving global health threats.